Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: hybrids of yellow jacket and paper wasp venom allergen antigen 5s.
about
Immunological mechanisms of allergen-specific immunotherapyThe major conformational IgE-binding epitopes of hevein (Hev b6.02) are identified by a novel chimera-based allergen epitope mapping strategy.Chimeras of Bet v 1 and Api g 1 reveal heterogeneous IgE responses in patients with birch pollen allergy.Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccinationIgE-binding epitopes: a reappraisal.A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.Genetically engineered vaccines.A naturally occurring hypoallergenic variant of vespid Antigen 5 from Polybia scutellaris venom as a candidate for allergen-specific immunotherapy.Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivityComprehensive 3D-modeling of allergenic proteins and amino acid composition of potential conformational IgE epitopes.From allergen genes to new forms of allergy diagnosis and treatment.100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.Adjuvants for allergy immunotherapeutics.Characterization of the human T cell response to antigen 5 from Vespula vulgaris (Ves v 5).Heterologous Expression, Purification and Immunoreactivity of the Antigen 5 from Polybia paulista Wasp VenomRecombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.Par j 1 and Par j 2, the major allergens from Parietaria judaica pollen, have similar immunoglobulin E epitopes.Chinese Guideline on allergen immunotherapy for allergic rhinitis.The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.
P2860
Q28265326-3FE1EA65-E3C1-4099-8335-CFA2CF297F20Q31044517-187196A1-1ACA-4546-B65C-FE984CC51AD7Q33858216-193CC6AF-A01E-4A5B-B9B9-5E0056D4CC96Q33883053-1199F048-1844-41F6-9CD2-988E3CBFD295Q33915536-A04CC890-7722-46B2-B25C-855595647CC5Q34588997-8589C03A-D491-4303-BF7A-4F97FEF2B804Q36103226-67F4636C-23A2-418C-B661-B60097E906B4Q36109834-088B8163-D166-467E-AA80-274B78C9054BQ36526262-20FD613C-31C9-4320-8480-66485E17B0C3Q36995548-0AE95194-E93E-4495-BD0D-D05804834F07Q37082959-462EDBB1-22CF-4BF1-AE3B-1846B09E9826Q37841682-F558F15A-B0E0-423C-88FD-CD5C64AFDFE8Q37958561-B232EFA5-7D67-48FF-8274-CD7DCCD37D80Q39151158-829A0649-8B87-4B37-BD81-DE06E21CDC18Q40443678-2F4B49B7-6B4A-4CCF-92C9-159A8AD7720AQ41669365-351C051B-C558-4589-9852-E5F885EDEEADQ41769755-D97C60AA-C775-4F03-A690-A8EA1E8B1C82Q44393841-D731E886-4CA3-4C8A-9B20-83A2A08AE9D1Q47149942-79615463-21D0-4932-96D0-CEA47D7C9979Q47988432-D0F09208-7F39-47AB-9E73-8FDD47333496Q55403212-CB2EA2E0-26EE-437E-9639-C8EEE9BA3F60
P2860
Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: hybrids of yellow jacket and paper wasp venom allergen antigen 5s.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Recombinant allergens with red ...... asp venom allergen antigen 5s.
@en
Recombinant allergens with red ...... asp venom allergen antigen 5s.
@nl
type
label
Recombinant allergens with red ...... asp venom allergen antigen 5s.
@en
Recombinant allergens with red ...... asp venom allergen antigen 5s.
@nl
prefLabel
Recombinant allergens with red ...... asp venom allergen antigen 5s.
@en
Recombinant allergens with red ...... asp venom allergen antigen 5s.
@nl
P2093
P1476
Recombinant allergens with red ...... wasp venom allergen antigen 5s
@en
P2093
A Kagey-Sobotka
L M Lichtenstein
M D Spangfort
P304
P356
10.4049/JIMMUNOL.166.10.6057
P407
P577
2001-05-01T00:00:00Z